INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Bharat Biotech and Thomas Jefferson University announced a promising vaccine candidate against COVID-19
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
Diffusion Pharma expanded clinical trial program of TSC for treatment of COVID-19 patients to include Romanian National Institute of Infectious Diseases
On May 20, 2020, Diffusion Pharmaceuticals announced it had entered into an agreement with the Romanian National Institute…
Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossaï¾’s proprietary…
NIH-funded study investigated pregnancy outcomes resulting from COVID-19 pandemic
On May 19, 2020, the NIH has launched a multipronged study to understand the effects of the COVID-19…
Oxford Immunotec released T-SPOT Discovery SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2
On May 19, 2020, the University of Oxford announced the release of the T-SPOT Discovery SARS-CoV-2 test kit….
The FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to accelarate Coronavirus disease research
On May 19, 2020, the FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to…
USC antibody study showed coronavirus infection more widespread in LA County than previously thought
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
Innovation Pharma’s Brilacidin reduced viral titer of SARS-CoV-2 by 75 percent after 1 hour of preincubation in an in vitro study
On May 19, 2020, Innovation Pharma announced that its anti-SARS-CoV-2 (COVID-19) drug candidate, Brilacidin, in an in vitro…
Bio-Techne and Kantaro Biosciences announced partnership to develop and scale production of COVID-19 serology test
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
Phlow Corp was awarded $354 million BARDA contract to manufacture essential medicines in shortage
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the NIH of Mexico and providing leronlimab…
Global study tested malaria drug to protect health workers from COVID-19
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
NantKwest announced FDA authorization of IND application for mesenchymal stem cell product for treatment of severe COVID-19 patients
On May 18, 2020, NantKwest announced it had received authorization from the FDA for an Investigational New Drug…
FDA cleared IND application to enable phase II trial of ViralClearï¾’s merimepodib to treat adult patients with advanced COVID-19 to proceed
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the FDA has completed its review…
Thermo Fisher Scientific support of COVID-19 response expanded with US Government contract for products used in sample collection
On May 18, 2020, Thermo Fisher Scientific announced it had received a contract from the U.S. government to…
Todos Medical announced first commercial sale of COVID-19 antibody tests
On May 18, 2020, Todos Medical announced its first commercial sale of COVID-19 tests. The sale was made…
Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
On May 16, 2020, a single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six…
Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology test
On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…
CIRM board approved clinical trials targeting COVID-19 and sickle cell disease
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
Abbott provided update on ID NOW
On May 14, 2020, Abbott’s ID NOW announced that was further clarifying product information to provide better guidance…
The FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care test
On May 14, 2020, the FDA alerted the public to early data that suggest potential inaccurate results from…
CureVac’s Optimized mRNA platform provides positive pre-clinical results at low dose for Coronavirus vaccine candidate
On May 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial
On May 14, 2020 Abivax announced it had received clearance from Franceï¾’s National Agency for the Safety of…
Vyriad announced development of new antibody test to determine protective immunity from COVID-19
On May 14, 2020 Vyriad announced that it had completed the development of a serology test to measure…
Countries begin large-scale screening for SARS-CoV-2 in sewage
On May 14, 2020,The Scientist reported that researchers from several countries including the US, Switzerland, Italy, the Netherlands,…
First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…
AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…
ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…